Slide 1: Strong order intake but temporary delivery disruptions had a negative impact on earnings
Strong order intake but temporary delivery disruptions had a negative impact on earnings Getinge Q3 2024 Mattias Perjos, CEO Agneta Palmér, CFO
Slide 2: Key takeaways Q3 2024
Key takeaways Q3 2024 • Order intake grew by 10.0% whereof 7.4% organically and net sales increased by 3.5% whereof 0.2% organically • Margins negatively impacted by volume, inflation and product mix – partly offset by price realizations • The financial position remains solid 33,591 34,000 55 13.0 3
Slide 3: Key activities and events
Key activities and events Q3 2024 Sustainability and Quality Offering and customers • Reinstated CE certificate for HLS and • Servo ventilators received cybersecurity clearance from US PLS consumables, used for ECLS Defense Health Agency therapy • Assets of Intact Solution LLC were acquired, includi
Slide 4: Organic order growth in all regions
Organic order growth in all regions Soft net sales in APAC in all Business Areas Global Americas EMEA APAC +7.4% Organic Order Growth +0.2% Organic Net Sales Growth Getinge │ Presentation │ Q3 Report 2024 October 18, 2024
Slide 5: Outlook 2024
Outlook 2024 Net sales for 2024 expected to increase by 2-5% organically (unchanged) Getinge │ Presentation │ Q3 Report 2024 October 18, 2024
Slide 6: Order Intake Bridge Q3 2023 – Q3 2024
Organic order growth in Surgical Workflows and Acute Care Therapies Order Intake Bridge Q3 2023 – Q3 2024 Organic change +10.6% -6.2% +8.2% +7.4% +10.0% 492 308 -25 8,486 7,712 MSEK Q3 2023 Acute Care Therapies Life Science Surgical Workflows Q3 2024 Getinge │ Presentation │ Q3 Report 2024 October 1
Slide 7: Net Sales Bridge Q3 2023 – Q3 2024
Soft organic sales in all Business Areas but Surgical Workflows Net Sales Bridge Q3 2023 – Q3 2024 Organic change -1.4% -2.4% +4.0% +0.2% +3.5% 392 -286 Currency impact, MSEK 46 1.3 -175 7,870 MSEK 7,607 Organic growth, % Q3 2023 Acute Care Life Science Surgical Q3 2024 -1.8 Therapies Workflows Capi
Slide 8: Adjusted Gross Profit Bridge Q3 2023 – Q3 2024
Adj Gross Margin declined in Acute Care Therapies versus last year Adjusted Gross Profit Bridge Q3 2023 – Q3 2024 Adj GM, % Q3 2024 54.8 38.5 42.5 48.3 (Q3 2023) (60.4) (35.6) (41.3) (51.1) Gross Margin impact -2.3% 46 196 Product and Geo mix -332 Cost inflation MSEK 3,799 Price 3,890 Currency Q3 20
Slide 9: Adjusted EBITA Bridge Q3 2023 – Q3 2024
Adj EBITA margin declined versus last year Adjusted EBITA Bridge Q3 2023 – Q3 2024 14.5% 11.5% Margin development -2.7 pp Adj GP +0.4 pp Adj OPEX -198 +0 pp D&A 28 -0.7 pp FX -91 -67 -15 -37 -17 -86 Currency impact, MSEK MSEK 1,101 903 Q3 2023 Adj Gross Adj Selling Adj Admin Adj R&D Other D&A Q3 202
Slide 10: Stable Free Cash Flow and Working Capital days trending down
Stable Free Cash Flow and Working Capital days trending down Capital efficiency a priority Positive Free Cash Flow WC days below 100 ROIC below trend, but still well above pre-pandemic levels 97 96 95 94 93 1.1 1.0 0.9 92 91 10.4% 8.5% 90 0.4 0.3 0 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q3 2023 Q4
Slide 11: Solid financial position
Solid financial position Recent acquisitions impacting net debt, but financial position is still strong Net debt increased due to acquisitions … … but leverage is still below 2.5x 11.3 2.0 9.0 8.0 7.6 1.4 1.4 1.5 3.8 2.0 (8.6 BSEK excl. pension 0.7 1.5 (1.5x excl. liabilities) pension liabilities) Q
Slide 12: Summary
Summary Getinge │ Presentation │ Q3 Report 2024 October 18, 2024
Slide 13: Key takeaways Summary Q3 2024
Key takeaways Summary Q3 2024 • Strong order intake growth and slightly positive net sales growth • Temporary supply challenges impacting margins • Solid financial position Getinge │ Presentation │ Q3 Report 2024 October 18, 2024
Slide 14: Q&A
Q&A Getinge │ Presentation │ Q3 Report 2024 October 18, 2024
Slide 15: Thank you
Thank you Getinge │ Presentation │ Q3 Report 2024 October 18, 2024
Slide 16: Forward looking information
Forward looking information This document contains forward-looking information based on the current expectations of the Getinge’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expectation
Slide 17: Getinge Passion for Life
| Se A GETINGE PASSION FOR LIFE